ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS Jul 16, 2025 02:15PM
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS Jul 12, 2025 10:01AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS Jul 5, 2025 04:10PM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS Jul 3, 2025 11:11PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS Jul 1, 2025 11:55AM


Jun 26, 2025 09:45PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
Jun 21, 2025 12:30PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
Jun 20, 2025 12:24PM ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
May 7, 2025 08:30AM GeneDx Announces Completion of Fabric Genomics Acquisition
Feb 26, 2024 04:05PM GeneDx to Participate in 44th Annual Cowen Health Care Conference
Feb 20, 2024 04:26PM GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
Feb 1, 2024 04:30PM GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 
Jan 24, 2024 04:30PM GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 1, 2023 08:30AM GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
Nov 28, 2023 04:05PM GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
Nov 20, 2023 04:05PM GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 30, 2023 04:05PM GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
Sep 22, 2023 04:05PM GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 11, 2023 08:00AM GeneDx Announces Evolution of Executive Leadership Team
Sep 11, 2023 08:00AM GeneDx Announces Evolution of Executive Leadership Team
Sep 6, 2023 08:00AM GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
Aug 21, 2023 07:00AM GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine
Aug 8, 2023 08:05PM GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 8, 2023 04:05PM GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights
Aug 7, 2023 08:00AM PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
Jul 19, 2023 07:05AM GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options
Jul 18, 2023 04:05PM GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
Jun 28, 2023 07:00AM GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium
Jun 26, 2023 04:01PM GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants
Jun 20, 2023 07:00AM GeneDx Commends the States of Arizona and Florida for Adding Rapid Whole Genome Sequencing (rWGS) as a Covered Benefit for Medicaid Pediatric Patients
May 24, 2023 04:05PM GeneDx to Participate in Upcoming Investor Conferences in June
May 23, 2023 07:00AM GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
May 9, 2023 04:05PM GeneDx Reports First Quarter 2023 Financial Results and Business Highlights
May 4, 2023 07:00AM GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option